Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,200 | 91,800 | 56,700 | 39,500 | 13,100 |
| Depreciation Amortization | 49,700 | 199,300 | 148,100 | 97,100 | 48,200 |
| Income taxes - deferred | -1,100 | -15,500 | -6,800 | -3,800 | -1,500 |
| Accounts receivable | 31,000 | -3,200 | 19,600 | 6,800 | 25,200 |
| Accounts payable and accrued liabilities | -42,300 | -1,300 | -40,200 | -21,000 | -48,100 |
| Other Working Capital | -56,000 | 75,900 | -11,200 | -15,200 | -37,000 |
| Other Operating Activity | 28,400 | 39,400 | 40,800 | 23,600 | 27,300 |
| Operating Cash Flow | $20,900 | $386,400 | $207,000 | $127,000 | $27,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,600 | -86,800 | -71,900 | -63,500 | -29,800 |
| Net Acquisitions | N/A | -156,800 | -156,800 | -31,700 | N/A |
| Other Investing Activity | 0 | 600 | 0 | 0 | 0 |
| Investing Cash Flow | $-16,600 | $-243,000 | $-228,700 | $-95,200 | $-29,800 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 700 | N/A | N/A | N/A | N/A |
| Debt Repayment | -10,300 | -22,800 | -17,600 | -13,900 | -8,900 |
| Common Stock Issued | 6,200 | 18,400 | 18,100 | 13,800 | 2,700 |
| Common Stock Repurchased | N/A | -10,000 | -10,000 | -10,000 | N/A |
| Dividend Paid | -44,600 | -175,900 | -131,700 | -87,500 | -43,600 |
| Other Financing Activity | 4,000 | -700 | -700 | -100 | 0 |
| Financing Cash Flow | $-44,000 | $-191,000 | $-141,900 | $-97,700 | $-49,800 |
| Beginning Cash Position | 196,300 | 243,900 | 243,900 | 243,900 | 243,900 |
| End Cash Position | 156,600 | 196,300 | 80,300 | 178,000 | 191,500 |
| Net Cash Flow | $-39,700 | $-47,600 | $-163,600 | $-65,900 | $-52,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,900 | 386,400 | 207,000 | 127,000 | 27,200 |
| Capital Expenditure | -18,500 | -144,500 | -103,300 | -75,300 | -30,700 |
| Free Cash Flow | 2,400 | 241,900 | 103,700 | 51,700 | -3,500 |